about
Intracranial hemorrhage in acute and chronic childhood immune thrombocytopenic purpura over a ten-year period: an Egyptian multicenter study.A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia.Cytokine gene polymorphism [tumor necrosis factor-alpha (-308), IL-10 (-1082), IL-6 (-174), IL-17F, 1RaVNTR] in pediatric patients with primary immune thrombocytopenia and response to different treatment modalities.Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: relationship to microvascular complications and bone mineral density.Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial.Cochleopathy in Egyptian adolescents with Type 1 diabetes mellitus.Current status of diabetes management, glycemic control and complications in children and adolescents with diabetes in Egypt. Where do we stand now? And where do we go from here?Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus.Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications.Recessively Inherited LRBA Mutations Cause Autoimmunity Presenting as Neonatal Diabetes.A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.Pulmonary complications in survivors of childhood hematological malignancies: single-center experience.Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo-controlled trial.ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study.An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.Pancreatic functions in adolescents with beta thalassemia major could predict cardiac and hepatic iron loading: relation to T2-star (T2*) magnetic resonance imaging.Prenatal ultrasonographic features of mature cystic teratoma in undescended testicle.Erratum. Recessively Inherited LRBA Mutations Cause Autoimmunity Presenting as Neonatal Diabetes. Diabetes 2017;66:2316-2322.Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness.Plasminogen activator inhibitor-1 (PAI-1) in children and adolescents with type 1 diabetes mellitus: relation to diabetic micro-vascular complications and carotid intima media thickness.Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetesCan optical coherence tomography predict early retinal microvascular pathology in type 1 diabetic adolescents without minimal diabetic retinopathy? A single-centre studyPlasma thrombin-activatable fibrinolysis inhibitor levels in children and adolescents with type 1 diabetes mellitusZinc supplementation improves glucose homeostasis in patients with β-thalassemia major complicated with diabetes mellitus: A randomized controlled trialVitamin B complex supplementation as a homocysteine-lowering therapy for early stage diabetic nephropathy in pediatric patients with type 1 diabetes: A randomized controlled trial
P50
Q33387292-95B6CD09-36D3-4A92-AFF2-C80B77C45CC3Q33421329-CC5557E7-A576-44E9-A6D0-E2653A28069EQ33430973-063B9873-FF99-4E92-B99D-89D103BA76A3Q34237592-46CFDCD1-D012-4E03-B364-A37E2E620C3BQ35614502-DDD73B35-F64B-46B7-84CB-8ED9A12285AFQ38990780-707D4E4B-5F88-4845-8CB2-B7394590E908Q39426404-7D577C2A-AA52-4EED-956D-3824EB06C47EQ40541420-8B9E64AC-91F7-405E-A49A-7B2008DC31BFQ40896469-56657387-780D-4465-B054-3A286B453150Q41104986-35082236-0169-4901-9E15-25D27B7726F1Q42870077-8BF45558-975B-4F45-9D0A-7E056D54FF20Q45030244-31FEA984-5C0D-4E65-90E8-8345DEEEC753Q46208616-D9C217E7-F9CC-4855-9597-200077E05D3DQ46210251-C842D163-F19B-4C71-8E60-E82E7086FA92Q46272931-568D3AA5-E77C-415F-AD24-56248F56EE1BQ46330764-795EFC86-04D3-422B-B46D-5378C60993BBQ46441613-B214EA4E-E144-4E58-9E7A-CFD03E677359Q46552680-DDCE8241-FA63-496D-81FA-0D193063F242Q46668115-25B8F367-B6E2-47E6-885D-189BAA1913C8Q47951619-AA90A30E-2BBA-44C8-B095-15E81C5B820FQ50157400-C723DC46-A88C-4B93-95E4-7DC78CE20689Q51283955-44D819AB-1896-4229-B984-28BC735153D4Q51326346-98309436-BBF1-4ADF-A6C5-AF98D5BEF5AAQ53773494-69FE28CB-8621-43D9-BE05-86A0F377B51CQ58870327-6A20474E-F284-4A46-A865-130DACAF79A7Q58870336-92F2E347-7E97-4376-8A8A-EDFD7F768585Q58870339-249C75F7-07BA-490F-BE50-12BF0EBF61CFQ89483695-E6248950-BD13-4A84-98AF-4661FAB82824Q91296038-B7058FD6-70D1-4115-BB69-E39B6F4B37B9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nancy Samir Elbarbary
@ast
Nancy Samir Elbarbary
@en
Nancy Samir Elbarbary
@es
Nancy Samir Elbarbary
@nl
type
label
Nancy Samir Elbarbary
@ast
Nancy Samir Elbarbary
@en
Nancy Samir Elbarbary
@es
Nancy Samir Elbarbary
@nl
prefLabel
Nancy Samir Elbarbary
@ast
Nancy Samir Elbarbary
@en
Nancy Samir Elbarbary
@es
Nancy Samir Elbarbary
@nl
P106
P1153
35725405100
P21
P31
P496
0000-0001-8713-0657